Biosciences

Kindred Widens Losses $KIN $XHS

Kindred Biosciences, Inc., has announced its results for the first quarter of FY-2015. The results shows EPS went improves from, -$0.38 to -$0.34 YoY, whereas cash and Equivalents also went down to $94.589 Million from $101.027 Million Quarterly. View the full earnings here.